Xencor | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 5.72B 1.98B 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amgen USD 2.66B 1.37B 2025-06
Arrowhead Research USD -165550000 546.75M 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Biogen USD 851.8M 540.6M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Cytokinetics USD -111506000 44.12M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
J&J USD 6.94B 6.69B 2025-06
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Xencor USD -33172000 10.01M 2025-06


Xencor L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.